| 47例肺大细胞癌临床分析 |
| |
| 引用本文： | 李小东,傅剑华,龙浩,林鹏,王欣,张兰军,马国伟,戎铁华.47例肺大细胞癌临床分析[J].中国肿瘤临床,2005,32(8):448-450. |
| |
| 作者姓名： | 李小东 傅剑华 龙浩 林鹏 王欣 张兰军 马国伟 戎铁华 |
| |
| 作者单位： | 中山大学附属肿瘤医院胸科,广州市,510060 |
| |
| 摘 要： | 目的:探讨肺大细胞癌的临床特点和治疗方法.方法:对47例肺大细胞癌的临床与病理资料进行分析.结果:肺大细胞癌占同期肺癌总数的0.7%;男女之比为23:1;中位生存期为25个月,5年生存率为19.1%,低于非小细胞肺癌的5年生存率(28.2%).结论:肺大细胞癌作为一种相对少见的病理类型,临床疗效较差,有必要进一步细分病理亚型并规范化综合治疗以提高疗效.
|
| 关 键 词： | 肺肿瘤 大细胞 预后 病理学 |
| 文章编号： | 1000-8179(2005)08-0448-03 |
A Clinical Review of 47 Patients with Large Cell Lung Cancer |
| |
| Li Xiaodong Fu Jianhua Long Hao et al.A Clinical Review of 47 Patients with Large Cell Lung Cancer[J].Chinese Journal of Clinical Oncology,2005,32(8):448-450. |
| |
| Authors: | Li Xiaodong Fu Jianhua Long Hao |
| |
| Institution: | Li Xiaodong Fu Jianhua Long Hao et al Department of Thoracic Surgery,Cancer Center of Zhongshan University,Guangzhou |
| |
| Abstract: | Objective: To study the clinic characteristics and therapeutic modality of large cell lung cancer (LCLC). Methods: Pathologic and clinical data of 47 inpatient cases in tumor center of Zhongshan university, from 1964~1999, were retrospectively reviewed. Results: LCLC accounted for 0.7% of all lung cancer patients in the corresponding term. The sex ratio between the male and the female patients was 23:1. The average survival time was 25 months. The 5-year survival rate was 19.1%, less than that of non-small cell lung cancer (28.2%). Conclusions: The therapeutic effectiveness of LCLC is poor, although it is a relatively less pathological type in lung cancer. Subdividing the pathology type of LCLC and standardized multimodality therapy maybe improve the therapeutic effectiveness of LCLC. |
| |
| Keywords: | Lung neoplasm Large cell Prognosis Pathology |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
